Products
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceHiro for Analytics
Synapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
2026 R&D Benchmark Report
Glossary
Free tools
NEWWebinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
No credit card required
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Why ruthenium is replacing copper in sub-10nm BEOL interconnects: the material physics, structural innovations, and patent evidence from TSMC, Samsung, IBM, and Applied Materials.
Article | Report Budesonide, NorUDCA, and FMT lead the microscopic colitis drug pipeline. Explore the evidence on bile acid, microbiome, and glucocorticoid approaches for CC and LC.
Article | Report How do FinFET and nanosheet transistors differ in leakage current at cryogenic temperatures? A patent and literature analysis covering DIBL, freeze-out, BTBT, and substrate leakage.
Article | Report Budesonide, NorUDCA, and FMT are reshaping the microscopic colitis drug pipeline. Explore the latest evidence on three therapeutic approaches targeting CC and LC.
Article | Report How CCUS technology integrates with industrial flue gas infrastructure: patent analysis covering pre-treatment, retrofit design, CO2 utilization, and leading innovators.
Article | Report Bistable mechanism technology in 2026: patent landscape, key innovators, MEMS, compliant structures, snap-through architectures, and emerging application domains.
Article | Report How to implement ISO 27001 cybersecurity controls in connected medical devices under FDA premarket guidance — covering proxy architectures, device provisioning, and threat modelling.
Article | Report A 2026 patent landscape of microrobotic capsule endoscopy: 28 years of innovation, 80+ records, AI navigation, electromagnetic actuation, and therapeutic payloads mapped.
Article | Report FXR agonists, PPAR modulators, RNAi, and CAR-Treg therapies are reshaping the PBC, AIH, and cholestatic liver disease pipeline. Explore the patent landscape.
Article | Report How does AI-powered visual inspection compare to traditional rule-based machine vision for surface defect classification? A patent-based technical analysis of 50+ filings.
Article | Report Mapping the 2026 PCFC patent landscape: BZCY electrolytes, leakage current barriers, hybrid architectures, and Japan's dominant IP position in proton ceramic fuel cells.
Article | Report A patent-driven analysis of magnetic shape memory alloy (MSMA) technology in 2026: key compositions, assignees, application domains, and emerging IP white spaces.
Article | Report How DIC improves strain measurement accuracy in fatigue testing of composite structures — full-field maps, error mitigation, crack detection, and aerospace applications.
Article | Report Mapping the MSMA patent landscape 2026: alloy compositions, actuator architectures, key assignees, and emerging directions across 30+ years of innovation.
Article | Report Analyse the CRC drug pipeline: VEGF/PD-1 combinations, KRAS G12C/G12D inhibitors, LAG-3, CD47/SIRPα blockade, and MEK triple-combination strategies shaping next-generation colorectal cancer therapy.